Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting
NCT ID: NCT00960648
Last Updated: 2010-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will compare EES (Xience/Promus, prospective arm) with sirolimus-eluting stent (SES, Cypher, retrospective arm).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
NCT00698607
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
NCT01605721
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205
Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)
NCT01348022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Xience/Promus
Active prospective registration of patients receiving everolimus eluting stent
Xience/Promus
Active prospective registration of patients receiving everolimus-eluting stent
Cypher
Retrospective historical controls that received sirolimus-eluting stent
Cypher
Retrospective historical controls that received sirolimus-eluting stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xience/Promus
Active prospective registration of patients receiving everolimus-eluting stent
Cypher
Retrospective historical controls that received sirolimus-eluting stent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Alternatively, a legally authorized patient representative may agree to the patient's participation in this study and sign the informed consent form.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Boston Scientific Corporation
INDUSTRY
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seoul National University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyo-Soo Kim, MD,PhD
Role: STUDY_CHAIR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dankook University Hospital
Cheonan, , South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, , South Korea
Kwangju Veterans Hospital
Gwangju, , South Korea
Chonbuk National University Hospital
Iksan, , South Korea
Wonkwang University Hospital
Iksan, , South Korea
Inje University Ilsan Paik Hospital
Ilsan, , South Korea
Gachon Kil Medical Center
Inchon, , South Korea
Chungbuk National University Hospital
Jeonju, , South Korea
Presbyterian Medical Center
Jeonju, , South Korea
Gyeongsang National University Hospital
Jinju, , South Korea
Inje University Pusan Paik Hospital
Pusan, , South Korea
Seoul National University Bundang Hospital
Seongnam, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Kyung Hee University Medical Center
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Yonsei University Medical Center
Seoul, , South Korea
St. Carollo Hospital
Suncheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EXCELLENT-REGISTRY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.